The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with … J Belch, A MacCuish, I Campbell, S Cobbe, R Taylor, R Prescott, R Lee, ... Bmj 337, a1840, 2008 | 929 | 2008 |
Low grade chronic inflammation in women with polycystic ovarian syndrome CCJ Kelly, H Lyall, JR Petrie, GW Gould, JMC Connell, N Sattar The Journal of Clinical Endocrinology & Metabolism 86 (6), 2453-2455, 2001 | 695 | 2001 |
Direct activation of AMP-activated protein kinase stimulates nitric-oxide synthesis in human aortic endothelial cells VA Morrow, F Foufelle, JMC Connell, JR Petrie, GW Gould, IP Salt Journal of Biological Chemistry 278 (34), 31629-31639, 2003 | 389 | 2003 |
Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010 SJ Livingstone, D Levin, HC Looker, RS Lindsay, SH Wild, N Joss, ... Jama 313 (1), 37-44, 2015 | 381 | 2015 |
Endothelial nitric oxide production and insulin sensitivity: a physiological link with implications for pathogenesis of cardiovascular disease JR Petrie, S Ueda, DJ Webb, HL Elliott, JMC Connell Circulation 93 (7), 1331-1333, 1996 | 372 | 1996 |
Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes RJ Strawbridge, J Dupuis, I Prokopenko, A Barker, E Ahlqvist, D Rybin, ... Diabetes 60 (10), 2624-2634, 2011 | 345 | 2011 |
Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease SJ CLELAND, N SATTAR, JR PETRIE, NG FOROUHI, HL ELLIOTT, ... Clinical science 98 (5), 531-535, 2000 | 336 | 2000 |
Altered vascular function in young women with polycystic ovary syndrome CJG Kelly, A Speirs, GW Gould, JR Petrie, H Lyall, JMC Connell The Journal of Clinical Endocrinology & Metabolism 87 (2), 742-746, 2002 | 293 | 2002 |
Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms JR Petrie, TJ Guzik, RM Touyz Canadian Journal of Cardiology 34 (5), 575-584, 2018 | 291 | 2018 |
Diabetes, left ventricular systolic dysfunction, and chronic heart failure MR MacDonald, MC Petrie, NM Hawkins, JR Petrie, M Fisher, R McKelvie, ... European heart journal 29 (10), 1224-1240, 2008 | 266 | 2008 |
Detailed physiologic characterization reveals diverse mechanisms for novel genetic Loci regulating glucose and insulin metabolism in humans E Ingelsson, C Langenberg, MF Hivert, I Prokopenko, V Lyssenko, ... diabetes 59 (5), 1266-1275, 2010 | 257 | 2010 |
Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage study SJ Livingstone, HC Looker, EJ Hothersall, SH Wild, RS Lindsay, ... PLoS Med 9 (10), e1001321, 2012 | 251 | 2012 |
Do men develop type 2 diabetes at lower body mass indices than women? J Logue, JJ Walker, HM Colhoun, GP Leese, RS Lindsay, JA McKnight, ... Diabetologia 54 (12), 3003-3006, 2011 | 220 | 2011 |
The atherogenic lipoprotein phenotype and vascular endothelial dysfunction N Sattar, JR Petrie, AJ Jaap Atherosclerosis 138 (2), 229-235, 1998 | 219 | 1998 |
Prevention of Progression of Arterial Disease and Diabetes Study Group; Diabetes Registry Group; Royal College of Physicians Edinburgh. The prevention of progression of … J Belch, A MacCuish, I Campbell, S Cobbe, R Taylor, R Prescott, R Lee, ... BMJ 337, a1840, 2008 | 216 | 2008 |
The use of metformin in type 1 diabetes: a systematic review of efficacy S Vella, L Buetow, P Royle, S Livingstone, HM Colhoun, JR Petrie Diabetologia 53 (5), 809-820, 2010 | 208 | 2010 |
Treatment of type 2 diabetes and outcomes in patients with heart failure: a nested case–control study from the UK General Practice Research Database MR MacDonald, DT Eurich, SR Majumdar, JD Lewsey, S Bhagra, ... Diabetes care 33 (6), 1213-1218, 2010 | 186 | 2010 |
Insulin as a vascular hormone: implications for the pathophysiology of cardiovascular disease SJ Cleland, JR Petrie, S Ueda, HL Elliott, JMC Connell Clinical and experimental pharmacology and physiology 25 (3‐4), 175-184, 1998 | 180 | 1998 |
Insulin resistance in type 1 diabetes: what is ‘double diabetes’ and what are the risks? SJ Cleland, BM Fisher, HM Colhoun, N Sattar, JR Petrie Diabetologia 56 (7), 1462-1470, 2013 | 177 | 2013 |
Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial JR Petrie, N Chaturvedi, I Ford, MCGJ Brouwers, N Greenlaw, T Tillin, ... The lancet Diabetes & endocrinology 5 (8), 597-609, 2017 | 175 | 2017 |